Mediproc

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Mediproc

What is Mediproc?

Mediproc is a pharmaceutical formulation containing the active ingredient medroxyprogesterone acetate. It belongs to a class of medications known as progestogens, which are synthetic versions of the naturally occurring female hormone progesterone.

Therapeutic Use

This medication is primarily used in the management of various conditions related to the female reproductive system. It functions by mimicking the effects of natural progesterone, which plays a critical role in regulating the menstrual cycle and maintaining the lining of the uterus.

Common Applications

Mediproc is frequently utilized in several clinical contexts, including:

  • Menstrual Cycle Regulation: It is used to treat absent or irregular menstrual periods by helping to establish a regular cycle.
  • Endometriosis: It may be used to manage the symptoms associated with endometriosis, a condition where tissue similar to the uterine lining grows outside the uterus.
  • Uterine Lining Protection: In certain hormone replacement therapies, it is used to prevent the overgrowth of the uterine lining.
  • Contraception: In specific formulations and dosages, it serves as a long-acting method of preventing pregnancy.

Mechanism of Action

Mediproc works by binding to progesterone receptors in the body. This interaction influences the secretion of gonadotropins from the pituitary gland, which in turn prevents ovulation and causes changes in the endometrium. These hormonal adjustments help stabilize the uterine environment and address symptoms caused by hormonal imbalances.

Regulatory References

  1. MedlinePlus Benzylpenicillin

What side effects are possible with Mediproc?

Possible side effects and safety information

The safety profile of Mediproc (Benzylpenicillin) is comprehensively documented in official regulatory classifications that detail potential adverse reactions by physiological system and frequency.

Hypersensitivity and Immunological Safety

The most critical safety consideration is the risk of hypersensitivity reactions, which can range from common skin manifestations like rash and urticaria to rare, but serious and occasionally fatal anaphylactoid reactions. Official labeling also documents the potential for severe cutaneous adverse reactions (SCAR), including Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). A history of allergy to any penicillin is an absolute contraindication for use. Furthermore, the possibility of cross-allergenicity to other beta-Lactam antibiotics is a recognized safety note.


System-Organ-Class Safety Overview

Adverse effects are officially grouped into System-Organ Classes (SOCs):

System-Organ Class Officially Documented Safety Concerns
Nervous System Seizures, encephalopathy, confusion (particularly with high doses or impaired renal function).
Gastrointestinal Diarrhoea, nausea, vomiting, and severe Clostridium difficile-associated diarrhoea (CDAD).
Blood/Lymphatic Neutropenia, haemolytic anaemia, and other blood disorders associated with prolonged, high-dose therapy.
Metabolism Electrolyte imbalances, such as hypernatraemia, due to the solute load of some formulations.

Population-Specific and Time-Related Safety

Safety notes for specific populations exist due to altered drug elimination. Patients with renal impairment have an increased risk of CNS toxicity. For newborns and infants, there are documented concerns regarding severe local reactions with intramuscular administration. Additionally, a time-dependent reaction known as the Jarisch-Herxheimer reaction may occur within hours of initial administration when treating syphilis, resulting from the rapid killing of the pathogen.

Overdose and Emergency Response

Overdose and when to seek help

The following information is based strictly on the documented manifestations and required emergency actions detailed in authoritative government regulatory sources.

Documented Overdose Presentations

High systemic concentrations of Mediproc (Benzylpenicillin) have the potential to cause dose-related Central Nervous System (CNS) toxicity. Officially documented manifestations include convulsive seizures, neuromuscular hyperirritability, confusion, and cerebral irritation, which may progress to encephalopathy and coma. Metabolic disturbances, such as hypernatraemia, are also documented with massive doses.

Aggravating Factors and Severe Outcomes

  • The risk of these toxic reactions is significantly greater in the presence of impaired renal function.
  • Accidental intravascular administration of concentrated formulations poses the risk of severe neurovascular damage, including gangrene and permanent paralysis; this complication is noted to occur most often in infants and small children.
  • Treatment is symptomatic and supportive. No specific antidote is listed in regulatory documentation. Monitoring of electrolyte balance and renal function is necessary during high-dose treatment.

Required Emergency Action

If overdose is suspected, or if any severe symptoms such as seizures or evidence of compromised circulation after injection occur, immediate medical attention is required.

  • Individuals must contact the local poison control center or emergency room immediately for prompt guidance and specialist consultation.

Therapeutic Uses of Mediproc

What Mediproc Treats: Main Uses and Benefits

Mediproc (Benzylpenicillin) is considered relevant in clinical settings that involve acute or unstable symptom patterns linked to conditions marked by increased physiological stress.

The medication is considered relevant for managing symptom clusters that may become intense or disruptive in conditions presenting with acute episodes, such as septicaemia, meningitis, severe pneumonia, and sub-acute bacterial endocarditis. It is also commonly used for specific bacterial diseases like syphilis and severe manifestations of Lyme disease, and in secondary prophylaxis to help manage symptoms associated with conditions like rheumatic fever.

Applied during phases when symptoms become more noticeable, such as symptoms related to systemic imbalance or symptoms related to inflammatory states, Mediproc may assist with symptomatic relief.

Quick Fact: Supportive Management for Systemic Symptom Patterns

Mediproc is applied in contexts involving heightened systemic burden to help ease overall symptom load, particularly the fever and generalized sickness associated with conditions marked by increased physiological stress. It is considered relevant for managing symptoms that interfere with daily comfort associated with deep tissue and organ-specific conditions like osteomyelitis.

Regulatory References

  1. Official Therapeutic Overview - HPRA

Eligibility and Restrictions for Use

Eligibility Scope

Population Category Eligibility Status (Regulatory Labeling)
Absolute Contraindication Individuals with a documented history of hypersensitivity (allergic reaction) to any penicillin or to any excipient in the specific formulation [FDA Label, EMA SmPC].
Age Groups Generally eligible for adults, adolescents, children, and infants. Use in neonates and older adults is often restricted based on individual renal function [FDA Label, EMA SmPC].
Renal Impairment Conditional Use is required for patients with severe renal impairment. The drug is not contraindicated, but regulatory labeling requires a mandatory adjustment of the dosing schedule due to delayed clearance and risk of neurotoxicity [FDA Label].
Pregnancy/Lactation Use is generally permitted when clearly indicated. Regulatory documents note that small amounts are excreted in breast milk, which is a consideration for the infant [TGA Prescribing Information, FDA Label].
Special Caution Groups Patients with a history of significant allergies or bronchial asthma are eligible but must be treated with caution due to the increased risk of severe hypersensitivity reactions [EMA SmPC].

Eligibility Structure Summary

Official regulatory documents define eligibility through a strict absolute exclusion for those with a known allergy to penicillins. All other eligible populations, including children, older adults, and those with severe kidney impairment, fall under conditional use. For these groups, eligibility requires careful consideration of the patient's physiological state, particularly renal function, which affects drug elimination and safety as detailed in the drug's label.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official Regulatory Interaction Profile

The interaction profile of Mediproc (Benzylpenicillin) focuses on documented effects concerning renal elimination, pharmacodynamic compatibility, and administration requirements as stated in official government labeling.

Interaction Type Interacting Substance(s) Official Documented Outcome
Pharmacokinetic (Clearance) Probenecid, NSAIDs (e.g., Aspirin, Indomethacin) Increases and prolongs the serum concentration of Benzylpenicillin by inhibiting its renal tubular secretion.
Exposure Modification Methotrexate Reduces the renal clearance of Methotrexate, which increases the risk of toxicity.
Pharmacodynamic Bacteriostatic Antibiotics (e.g., Tetracyclines, Chloramphenicol) Combination is officially not recommended or contraindicated due to the potential for antagonistic reduction of the bactericidal effect.
Pharmacodynamic Oral Anticoagulants (e.g., Warfarin) May increase the anticoagulant activities.

Administration and Population Notes

Timing-Based Rule: Benzylpenicillin must not be mixed with Aminoglycoside antibiotics in the same intravenous container due to chemical and activity incompatibility.

Population Consideration: The high sodium load in Benzylpenicillin sodium requires formal consideration for patients with pre-existing renal impairment or heart failure to mitigate the risk of sodium overload, a restriction noted in official product information.

Mechanism of Action

How Mediproc Works: Mechanism of Action

Mediproc (Benzylpenicillin) exerts its function through specific biological processes aimed exclusively at the bacterial structure. Its mechanism is fundamentally bactericidal, meaning it acts by directly destroying the pathogen rather than simply inhibiting its growth.


Blocking the Bacterial Cell Wall Assembly

The primary mechanistic domain involves the irreversible inhibition of bacterial transpeptidases, a family of enzymes known as Penicillin-Binding Proteins (PBPs). Mediproc's molecular structure binds permanently to the PBP active site, blocking the final cross-linking step of peptidoglycan synthesis. This molecular blockade immediately stops the pathogen from properly constructing its rigid, protective cell wall.


Cell Lysis and Pathogen Destruction

The inhibition of cell wall assembly initiates a fatal physiological cascade. The defective cell wall cannot withstand the high internal osmotic pressure of the bacteria, leading to structural breakdown and simultaneous activation of the pathogen's own degradation enzymes (autolysins). This combined effect causes the bacterial cell to rapidly swell and rupture (cell lysis), resulting in the destruction of the susceptible pathogen population.


Mechanistic Limitations: The Role of beta-Lactamase

The mechanism's efficacy is biologically limited by bacterial defense systems. Certain resistant pathogens produce beta-Lactamase enzymes, which chemically hydrolyze the drug's critical beta-lactam ring, thereby inactivating the drug before it can reach the PBP target. Furthermore, the bactericidal action is largely dependent on the bacteria being in a phase of active growth and division.

Dosage and Administration Information

Mediproc should be used exactly as prescribed by a licensed healthcare provider. Adherence to the prescribed regimen is critical for the medication's effectiveness and to mitigate the risk of adverse events. Do not modify the dose, frequency, or duration of therapy without first consulting your physician or pharmacist, even if you feel your symptoms have improved or worsened.

Administration Guidelines

  • Dosing: The prescribed dosage is determined based on individual health factors, including the condition being treated and other medications taken. Never take a larger dose than prescribed, as this can be dangerous.
  • Timing: Take Mediproc at the same time each day to maintain a steady level of the drug in your body. If you miss a dose, consult the specific instructions provided with the drug or contact your pharmacist for guidance. Do not double your dose to make up for a missed one.
  • Method: Unless otherwise instructed by your prescriber, swallow the tablet whole with a full glass of water. Do not crush, chew, or break the tablet, as this may alter the drug's intended release into the body and impact its efficacy or safety profile.

Storage and Safety

Medication must be stored at room temperature, away from excessive heat and moisture, and out of the reach of children and pets. Check the expiration date before taking any dose; expired medicines may not work correctly and could potentially be harmful. Always keep an updated list of all your medications, including prescription, over-the-counter drugs, and supplements, to share with your healthcare team to prevent potential drug interactions.

Recent Clinical Evidence

Research evidence / Overview of studies for Mediproc (Benzylpenicillin)

This section provides an overview of the types of research and studies that have explored the clinical use of Mediproc (Benzylpenicillin), describing what has been observed in study settings and what remains uncertain. Research provides context but not individual predictions.


Evidence for Use in Acute Systemic Infections

The research exploring the use of Mediproc for severe, systemic conditions, including septicaemia, meningitis, and severe pneumonia, relies on a foundation of historical Randomized Controlled Trials (RCTs) and Systematic Reviews. These studies describe outcomes such as mortality and pathogen status in adults and children. Findings describe patterns related to symptom change and microbiological status. Regulatory bodies classify the research base for sensitive pathogens in these scenarios as having a High evidence level. However, much foundational research is historical, and limited data apply to newly emerging resistant bacterial strains.


Evidence for Treatment of Endocarditis and Specific Bacterial Diseases

Studies evaluating conditions like sub-acute bacterial endocarditis were primarily long-term Observational Cohort Studies, examining measurements of pathogen status, heart valve function, and recurrence. For syphilis and severe Lyme disease, research involved Comparative Clinical Trials and specialized Long-term Serological Follow-up Studies, measuring serological response and the evolution of severe symptoms. The evidence quality varies across studies, with functional outcomes in complex infections often difficult to measure consistently.


Evidence for Prevention and Prophylactic Use

Research examining Mediproc for secondary prevention in conditions like rheumatic fever is derived from Very Long-term Epidemiological Observational Studies. These studies monitored rates of recurrent episodes and the progression of structural heart damage. Data show patterns related to lower recurrence rates in populations receiving continuous management. The research base is classified as High evidence, but this reliance on consistent long-standing data limits modern comparative RCTs.


Research Gaps and Areas of Uncertainty

Research has explored patterns of change over time across various indications, but long-term effects are not fully established for all outcomes. Studies have examined specific groups like children and disease severity cohorts, yet certain subgroup findings are uncertain or based on smaller sample sizes. A key limitation is the reliance on historical trial data, where current standards of care may differ. Furthermore, evidence quality varies, and research remains limited regarding study findings in newer resistant bacterial infections.

Key Studies & References

  1. Official Therapeutic Overview (HPRA) - Benzylpenicillin (PA2059/085/002)
  2. IDSA Guidelines for the Management of Bacterial Meningitis

Frequently Asked Questions (FAQ)

Common questions about Mediproc (FAQ)


Q: What are the most commonly reported side effects of Mediproc?

Official documentation groups potential side effects by body system. Commonly reported adverse effects are often related to the digestive tract and include issues such as diarrhea, nausea, and vomiting. The most critical safety consideration noted in official sources is the potential for hypersensitivity reactions, such as rash or hives, which can occur frequently and vary greatly in severity.

Q: Is it common to feel tired when starting Mediproc?

Official regulatory documents do not consistently list general fatigue or unusual tiredness as a common, isolated side effect of Mediproc (Benzylpenicillin). However, other central nervous system (CNS) issues, such as confusion, are documented, particularly with high doses or kidney issues. Concerns about unusual or persistent tiredness are best addressed by a healthcare provider.

Q: What happens if I stop taking Mediproc suddenly?

Official drug labeling strongly emphasizes the critical need to complete the full, prescribed course of treatment. Stopping the medication abruptly, before the course is finished, may lead to the re-emergence or worsening of the original infection. It can also contribute to the development of drug-resistant bacteria in the body.

Q: Can Mediproc affect mood or cause anxiety?

The official safety profile for Mediproc includes a range of nervous system (CNS) effects, such as seizures, confusion, and encephalopathy, especially at high doses or in patients with kidney impairment. While anxiety is not always explicitly listed, some official warnings or reports list it with other Central Nervous System (CNS) effects.

Q: What kind of monitoring is needed while taking Mediproc?

For patients with conditions like renal impairment or heart failure, official product information requires formal consideration regarding the drug's high sodium load. This may necessitate the monitoring of electrolytes (like sodium) and kidney function (such as creatinine levels) through tests as part of the management plan.

Q: Is Mediproc safe to use long-term?

Regulatory documents state that prolonged, high-dose therapy has been associated with documented safety concerns, including specific blood disorders (like neutropenia). Research overviews describe the use of this drug for specific conditions over extended periods, while noting that long-term effects are not fully established for all outcomes.

Q: Can Mediproc affect blood sugar levels?

Official safety data lists adverse effects related to Metabolism, specifically mentioning electrolyte imbalances such as hypernatraemia (high sodium). There is no consistent mention in core regulatory documents linking Mediproc (Benzylpenicillin) to direct effects on blood sugar or glucose levels.

Q: Does Mediproc interact with birth control pills?

The official interaction profile lists specific drug-to-drug interactions (such as Probenecid or Methotrexate). Regulatory-aligned resources suggest that alternative non-hormonal methods of contraception may be considered when taking antibiotics in the beta-lactam class, as advised by a healthcare provider.

Q: What is the duration of treatment generally recommended for Mediproc?

The appropriate duration of treatment is specific to the bacterial infection being addressed. Regulatory-aligned guidelines for systemic infections often specify treatment durations ranging from 7 to 14 days or longer for chronic management, which is determined on an individual basis.

Q: Can Mediproc cause weight gain or loss?

Unusual weight loss or weight gain are mentioned in regulatory-aligned resources as possible, less common adverse reactions documented for penicillin-related drugs. These are not typically listed among the expected or commonly reported side effects.

Q: Is Mediproc approved for use in children?

Yes, Mediproc (Benzylpenicillin) is officially indicated and approved for use in a wide range of age groups, including adults, adolescents, children, newborn infants, and premature infants. Official documentation states that the required dosage and administration route are adjusted based on the patient's age and weight.

Q: What is the difference between Mediproc and a similar sounding drug, Mediprox?

Mediproc contains the active ingredient Benzylpenicillin (Penicillin G), which is officially classified as a natural beta-Lactam antibiotic used to treat specific bacterial infections. Regulatory documents focus solely on describing the properties and uses of Benzylpenicillin and do not contain comparative information regarding other named substances.

Q: Is Mediproc available over the counter anywhere?

No. Mediproc (Benzylpenicillin) is consistently categorized in regulatory documents globally as a prescription-only medicine. Its use requires authorization and a prescription from a licensed healthcare provider.

Q: What official warnings or boxed warnings are associated with Mediproc?

Official documentation, including FDA labeling, highlights the critical risk of Hypersensitivity Reactions as the most serious safety concern. The FDA uses the term Boxed Warning to prominently display this warning on the label, specifically concerning the risk of severe allergic reactions, including anaphylaxis.

Q: What is the risk of developing tolerance to Mediproc?

The term drug tolerance (where the drug's effect decreases over time) is not generally addressed in standard regulatory patient information. However, the official process of Penicillin Tolerance Induction (desensitization) is a recognized clinical procedure required for certain patients with a confirmed penicillin allergy.

Q: Why do some people experience stomach upset with Mediproc?

Official adverse reaction lists commonly include gastrointestinal effects like nausea and diarrhea. These symptoms are generally consistent with antibiotic use which can temporarily affect the natural balance of microorganisms (gut flora) in the digestive tract. Regulatory documents do not provide a detailed pharmacological explanation for general stomach upset.

Q: How long does Mediproc stay in your system after stopping?

Regulatory documents, found in the pharmacokinetics section, note that Benzylpenicillin has a very short elimination half-life, which ranges from approximately 30 minutes to 1.4 hours. This means the drug is typically cleared from the body within several hours after the final dose.

Q: Are there generic versions of Mediproc available?

Yes. Mediproc is the term used for the active substance Benzylpenicillin (Penicillin G). This is a well-established drug that is available globally from multiple manufacturers under various generic names, such as Benzylpenicillin Sodium or Potassium, as listed in regulatory approval databases.

Q: How frequently is Mediproc usually taken?

The frequency of administration depends on the type and severity of the infection being treated. Official guidelines for systemic infections often describe administration by injection as frequently as every 4 to 6 hours, based on the drug's short half-life and the need to maintain a continuous therapeutic level.

Q: Are there demographic restrictions (like gender or ethnicity) on who can use Mediproc?

Official regulatory documents define eligibility based on age, history of allergy, and co-existing conditions such as kidney or heart impairment. No restrictions on use are detailed in regulatory labeling based on gender or ethnicity.

Q: What is the likelihood of having a serious interaction with Mediproc?

The most serious event is the risk of a severe allergic reaction (anaphylaxis), which is rare but requires immediate attention. Officially documented drug interactions may increase the concentration of Mediproc in the blood, which increases the risk of side effects like seizures.

Q: Are the side effects of Mediproc permanent?

Most side effects described in regulatory safety data, such as gastrointestinal upset or a mild rash, are generally considered to be reversible and resolve after stopping the medication. Serious, rare adverse effects (e.g., severe cutaneous reactions) may potentially have long-term consequences, but their occurrence is infrequent.

Q: How is the effectiveness of Mediproc typically measured in research?

Research evaluating Mediproc (Benzylpenicillin) measures effectiveness using both clinical and microbiological endpoints. These measurements include rates of pathogen clearance (the elimination of the target bacteria) and functional outcomes like symptom change or survival in serious systemic infections.

Q: Is the onset of action different between the tablet and liquid forms of Mediproc?

This medication is primarily formulated as a powder for injection (parenteral administration). The active ingredient is highly sensitive to stomach acid, which would prevent effective absorption and action if it were commonly taken as a tablet or liquid by mouth.

Q: Does Mediproc carry a risk of dependence?

Mediproc (Benzylpenicillin) is an anti-infective agent. Regulatory documentation does not classify this substance as having a risk of dependence or abuse potential.

Q: Do regulatory agencies list any potential long-term risks with Mediproc?

Yes. Regulatory documents list long-term risks that include the possibility of certain blood disorders with prolonged, high-dose use. Regulatory-aligned research overviews also state that long-term effects are not fully established for all outcomes across all possible indications.

Q: Can Mediproc be taken with antacids?

Official drug interaction checks generally indicate there is no known interaction between Mediproc (Penicillin G potassium) and common antacids containing ingredients like calcium carbonate. A healthcare provider can offer guidance on concurrent use.

Q: Is it better to take Mediproc in the morning or at night?

Official guidelines specify that the medication should be taken or administered at the same time each day to maintain a steady level in the body. The specific time of day (morning or night) is not universally specified and is determined by the prescriber based on the prescribed dosing frequency.

How should Mediproc be stored and disposed of?

How to Store and Dispose of Mediproc (Benzylpenicillin)?

Storage and disposal instructions for Mediproc (Benzylpenicillin Powder for Injection) are defined in official regulatory labeling to ensure product stability and safety.

Scope Requirement (Official Statement)
Storage Temperature Store below 25°C (77°F).
Environmental Protection Protect from light and moisture.
Packaging Rule Must be kept in the original container.
Child Safety Keep out of the sight and reach of children.
Stability After Mixing The reconstituted solution must be used immediately.

All unused, expired, or residual Mediproc must be disposed of according to local requirements for medicinal waste. The product must not be disposed of in wastewater or household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Mediproc found in:

A-Z Index: